Motley gave kudos to Aph though in the Investor takeaway....Investor takeaway: Its possible that the recent outperformance by the underdog may be temporary, as the bigger competitor has the whims and firepower to reclaim its leading position on the margins and cost-management front. Organigram may record increases in cost of sales and declining gross margins as it outsources cannabis oil extraction services from third parties in the near future due to internal capacity constraints, yet Aphria could commission its low-cost Extraction Centre of Excellence by May this year.